1
|
Zgadzaj R, Welch J, Cao Y, Amorim LD, Cheng A, Gaikwad A, Iapozzutto P, Kumar P, Litvinenko VN, Petrushina I, Samulyak R, Vafaei-Najafabadi N, Joshi C, Zhang C, Babzien M, Fedurin M, Kupfer R, Kusche K, Palmer MA, Pogorelsky IV, Polyanskiy MN, Swinson C, Downer MC. Plasma electron acceleration driven by a long-wave-infrared laser. Nat Commun 2024; 15:4037. [PMID: 38740793 DOI: 10.1038/s41467-024-48413-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2023] [Accepted: 04/29/2024] [Indexed: 05/16/2024] Open
Abstract
Laser-driven plasma accelerators provide tabletop sources of relativistic electron bunches and femtosecond x-ray pulses, but usually require petawatt-class solid-state-laser pulses of wavelength λL ~ 1 μm. Longer-λL lasers can potentially accelerate higher-quality bunches, since they require less power to drive larger wakes in less dense plasma. Here, we report on a self-injecting plasma accelerator driven by a long-wave-infrared laser: a chirped-pulse-amplified CO2 laser (λL ≈ 10 μm). Through optical scattering experiments, we observed wakes that 4-ps CO2 pulses with < 1/2 terawatt (TW) peak power drove in hydrogen plasma of electron density down to 4 × 1017 cm-3 (1/100 atmospheric density) via a self-modulation (SM) instability. Shorter, more powerful CO2 pulses drove wakes in plasma down to 3 × 1016 cm-3 that captured and accelerated plasma electrons to relativistic energy. Collimated quasi-monoenergetic features in the electron output marked the onset of a transition from SM to bubble-regime acceleration, portending future higher-quality accelerators driven by yet shorter, more powerful pulses.
Collapse
Affiliation(s)
- R Zgadzaj
- University of Texas at Austin, 2515 Speedway C1600, Austin, TX, 78712, USA
| | - J Welch
- University of Texas at Austin, 2515 Speedway C1600, Austin, TX, 78712, USA
| | - Y Cao
- University of Texas at Austin, 2515 Speedway C1600, Austin, TX, 78712, USA
| | - L D Amorim
- Stony Brook University, Stony Brook, NY, 11794, USA
| | - A Cheng
- Stony Brook University, Stony Brook, NY, 11794, USA
| | - A Gaikwad
- Stony Brook University, Stony Brook, NY, 11794, USA
| | - P Iapozzutto
- Stony Brook University, Stony Brook, NY, 11794, USA
| | - P Kumar
- Stony Brook University, Stony Brook, NY, 11794, USA
| | | | - I Petrushina
- Stony Brook University, Stony Brook, NY, 11794, USA
| | - R Samulyak
- Stony Brook University, Stony Brook, NY, 11794, USA
| | | | - C Joshi
- University of California at Los Angeles, Los Angeles, CA, 90024, USA
| | - C Zhang
- University of California at Los Angeles, Los Angeles, CA, 90024, USA
| | - M Babzien
- Brookhaven National Laboratory, Upton, NY, 11973, USA
| | - M Fedurin
- Brookhaven National Laboratory, Upton, NY, 11973, USA
| | - R Kupfer
- Brookhaven National Laboratory, Upton, NY, 11973, USA
| | - K Kusche
- Brookhaven National Laboratory, Upton, NY, 11973, USA
| | - M A Palmer
- Brookhaven National Laboratory, Upton, NY, 11973, USA
| | | | | | - C Swinson
- Brookhaven National Laboratory, Upton, NY, 11973, USA
| | - M C Downer
- University of Texas at Austin, 2515 Speedway C1600, Austin, TX, 78712, USA.
| |
Collapse
|
2
|
Beeks K, Sikorsky T, Rosecker V, Pressler M, Schaden F, Werban D, Hosseini N, Rudischer L, Schneider F, Berwian P, Friedrich J, Hainz D, Welch J, Sterba JH, Kazakov G, Schumm T. Growth and characterization of thorium-doped calcium fluoride single crystals. Sci Rep 2023; 13:3897. [PMID: 36890210 PMCID: PMC9995343 DOI: 10.1038/s41598-023-31045-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2023] [Accepted: 03/06/2023] [Indexed: 03/10/2023] Open
Abstract
We have grown [Formula: see text]Th:CaF[Formula: see text] and [Formula: see text]Th:CaF[Formula: see text] single crystals for investigations on the VUV laser-accessible first nuclear excited state of [Formula: see text]Th, with the aim of building a solid-state nuclear clock. To reach high doping concentrations despite the extreme scarcity (and radioactivity) of [Formula: see text]Th, we have scaled down the crystal volume by a factor 100 compared to established commercial or scientific growth processes. We use the vertical gradient freeze method on 3.2 mm diameter seed single crystals with a 2 mm drilled pocket, filled with a co-precipitated CaF[Formula: see text]:ThF[Formula: see text]:PbF[Formula: see text] powder in order to grow single crystals. Concentrations of [Formula: see text] cm[Formula: see text] have been realized with [Formula: see text]Th with good (> 10%) VUV transmission. However, the intrinsic radioactivity of [Formula: see text]Th drives radio-induced dissociation during growth and radiation damage after solidification. Both lead to a degradation of VUV transmission, currently limiting the [Formula: see text]Th concentration to [Formula: see text] cm[Formula: see text].
Collapse
Affiliation(s)
- Kjeld Beeks
- Laboratory for Ultrafast Microscopy and Electron Scattering (LUMES), Institute of Physics, École Polytechnique Fédérale de Lausanne (EPFL), Station 6, 1015, Lausanne, Switzerland.
| | - Tomas Sikorsky
- Institute for Atomic and Subatomic Physics, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Veronika Rosecker
- Institute for Atomic and Subatomic Physics, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Martin Pressler
- Institute for Atomic and Subatomic Physics, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Fabian Schaden
- Institute for Atomic and Subatomic Physics, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - David Werban
- Institute for Atomic and Subatomic Physics, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Niyusha Hosseini
- Institute for Atomic and Subatomic Physics, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Lukas Rudischer
- Institute for Atomic and Subatomic Physics, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Felix Schneider
- Institute for Atomic and Subatomic Physics, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Patrick Berwian
- Fraunhofer-Institut für Integrierte Systeme und Bauelementetechnologie IISB, Schottkystraße 10, 91058, Erlangen, Germany
| | - Jochen Friedrich
- Fraunhofer-Institut für Integrierte Systeme und Bauelementetechnologie IISB, Schottkystraße 10, 91058, Erlangen, Germany
| | - Dieter Hainz
- TRIGA Center Atominstitut, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Jan Welch
- CLIP, TRIGA Center Atominstitut TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Johannes H Sterba
- CLIP, TRIGA Center Atominstitut TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Georgy Kazakov
- Institute for Atomic and Subatomic Physics, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| | - Thorsten Schumm
- Institute for Atomic and Subatomic Physics, TU Wien, Stadionallee 2, 1020, Vienna, Austria
| |
Collapse
|
3
|
Musey P, Kelker H, Yoder K, Henderson B, Johnson O, Sarmiento E, Harris M, Vyas P, Welch J. 221 Impact of the COVID Pandemic on Emergency Physician Well-Being and Burnout: A 2-Year Longitudinal Study. Ann Emerg Med 2022. [DOI: 10.1016/j.annemergmed.2022.08.245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
4
|
Kelker H, Cushman E, Munson C, Yoder K, Musey P, Reed K, Henderson B, Vynas P, Johnson O, Welch J. 99 Identifying Factors that Contribute to Joy and Gratitude for Emergency Medicine Health Care Providers Amidst the COVID-19 Pandemic. Ann Emerg Med 2021. [DOI: 10.1016/j.annemergmed.2021.07.101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
5
|
McLeod GFH, Cleland L, Welch J, Spittlehouse JK, Fenton A, Boden JM, Horwood LJ. Menopause status and climacteric symptoms in a birth cohort of mid-life New Zealand women. Climacteric 2021; 25:271-277. [PMID: 34269148 DOI: 10.1080/13697137.2021.1948005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
BACKGROUND There is little current research on the transition to natural menopause among contemporary groups of mid-life women at age 40 years. OBJECTIVE This study reports on female members of the Christchurch Health and Development Study cohort. This research aimed to: document the menopause status, reproductive outcomes and climacteric symptoms of the women at age 40 years; examine the associations between menopause status and concurrent measures of psychosocial and economic well-being; and document the associations between menopause status and potential predictors of menopause reflecting childhood, family and individual factors prior to age 40 years. METHODS The Christchurch Health and Development Study is a longitudinal, representative, prospective cohort of 1265 babies (630 females) born in New Zealand in 1977. At age 40 years, 470 women (who had not experienced surgical menopause) were interviewed on their menopause status, climacteric symptoms and associated factors. RESULTS The majority of women were premenopausal, around 20% were perimenopausal and 2% were postmenopausal. Statistically significant associations were found reflecting higher rates of diagnosed reproductive disorder, climacteric symptoms, low occupational status, non-heterosexual sexuality and exposure to childhood sexual abuse amongst both perimenopausal and postmenopausal women at age 40 years. CONCLUSION These data will inform directions for future data collection and analyses.
Collapse
Affiliation(s)
- G F H McLeod
- Christchurch Health and Development Study, Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
| | - L Cleland
- Christchurch Health and Development Study, Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
| | - J Welch
- Christchurch Health and Development Study, Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
| | - J K Spittlehouse
- Christchurch Health and Development Study, Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
| | - A Fenton
- Oxford Women's Health, Christchurch, New Zealand
| | - J M Boden
- Christchurch Health and Development Study, Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
| | - L J Horwood
- Christchurch Health and Development Study, Department of Psychological Medicine, University of Otago, Christchurch, New Zealand
| |
Collapse
|
6
|
Feldsine PT, Leung SC, Lienau AH, Mui LA, Townsend DE, Arling V, August L, Barham D, Bohnert M, Boville A, Brookman S, Chavey C, Clements S, Davis R, Devane S, Dissel S, Gartside S, Hagel D, Hernandez C, Hopkins S, Howell M, Humbert F, Hunsucker J, Jackson J, Koch S, Kuber C, Lamb J, Lewis L, Lightfoot B, Lin W, Musch S, Nieves K, Poumeyrol M, Qvist S, Rice J, Solis D, Terry J, in’t Veld P, Voermans R, Warburton D, Welch J. Enumeration of Total Aerobic Microorganisms in Foods by SimPlate® Total Plate Count–Color Indicator Methods and Conventional Culture Methods: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/86.2.257] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
The relative efficacy of the SimPlate® Total Plate Count–Color Indicator (TPC–CI) method (SimPlate 35°C) was compared with the AOAC Official Method 966.23 (AOAC 35°C) for enumeration of total aerobic microorganisms in foods. The SimPlate TPC–CI method, incubated at 30°C (SimPlate 30°C), was also compared with the International Organization for Standardization (ISO) 4833 method (ISO 30°C). Six food types were analyzed: ground black pepper, flour, nut meats, frozen hamburger patties, frozen fruits, and fresh vegetables. All foods tested were naturally contaminated. Nineteen laboratories throughout North America and Europe participated in the study. Three method comparisons were conducted. In general, there was <0.3 mean log count difference in recovery among the SimPlate methods and their corresponding reference methods. Mean log counts between the 2 reference methods were also very similar. Repeatability (sr) and reproducibility (sR) standard deviations were similar among the 3 method comparisons. The SimPlate method (35°C) and the AOAC method were comparable for enumerating total aerobic microorganisms in foods. Similarly, the SimPlate method (30°C) was comparable to the ISO method when samples were prepared and incubated according to the ISO method.
Collapse
Affiliation(s)
| | | | - Andrew H Lienau
- BioControl Systems Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | - Linda A Mui
- BioControl Systems Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Pedersen K, Foster N, Overman M, Boland P, Kim S, Arrambide K, Jaszewski B, Welch J, Wilson R, McWilliams R. ZEBRA: an ACCRU/IRCI multicenter phase 2 study of pembrolizumab in patients with advanced small bowel adenocarcinoma (SBA). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz154.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
8
|
Rizan C, Montgomery J, Ramage C, Welch J, Dewhurst G. Why are UK junior doctors taking time out of training and what are their experiences? A qualitative study. J R Soc Med 2019; 112:192-199. [PMID: 30963774 DOI: 10.1177/0141076819831872] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
OBJECTIVES The number of doctors directly entering UK specialty training after their foundation year 2 (F2) has steadily declined from 83% in 2010 to 42.6% in 2017. The year following F2, outside the UK training pathway, is informally termed an 'F3' year. There is a paucity of qualitative research exploring why increasingly doctors are taking F3s. The aim of this study is to explore the reasons why F2 doctors are choosing to take a year out of training and the impact upon future career choices. DESIGN This is an exploratory qualitative study, using in-depth interviews and content analysis. SETTING UK. PARTICIPANTS Fourteen participants were interviewed from one foundation school. Participants included five doctors who commenced their F3 in 2015, five who started in 2016 and finally four recently starting this in 2017. MAIN OUTCOME MEASURES Content analysis was conducted to distill the themes which exemplified the totality of the experience of the three groups. RESULTS There were four predominant themes arising within the data set which can be framed as 'unmet needs' arising within foundation years, sought to be fulfilled by the F3 year. First, doctors describe exhaustion and stress resulting in a need for a 'break'. Second, doctors required more time to make decisions surrounding specialty applications and prepare competitive portfolios. Third, participants felt a loss of control which was (partially) regained during their F3s. The final theme was the impact of taking time out upon return to training (for those participants who had completed their F3 year). When doctors returned to NHS posts they brought valuable experience. CONCLUSIONS This study provides evidence to support the important ongoing initiatives from Health Education England and other postgraduate bodies, exploring approaches to further engage, retain and support the junior doctor workforce.
Collapse
Affiliation(s)
- Chantelle Rizan
- 1 Brighton and Sussex University Hospitals NHS Trust, Brighton BN2 5BE, UK
| | | | - Charlotte Ramage
- 3 School of Health Sciences, University of Brighton, Brighton BN1 9QW, UK
| | - Jan Welch
- 4 South Thames Foundation School, London SE1 9RT, UK
| | - Graeme Dewhurst
- 5 Health Education England Kent Surrey and Sussex, London WC1B 5DN, UK
| |
Collapse
|
9
|
Rao S, Sclafani F, Eng C, Grønlie Guren M, Adams R, Benson A, Sebag-Montefiore D, Segelov E, Bryant A, Peckitt C, Roy A, Seymour M, Welch J, Saunders M, Muirhead R, Bridgewater J, Falk S, Glynne-Jones R, Arnold D, Cunningham D. InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy424.022] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
10
|
Morgan C, Cira M, Karagu A, Asirwa FC, Brand NR, Buchanan Lunsford N, Dawsey SM, Galassi A, Korir A, Kupfer L, Loehrer PJ, Makumi D, Muchiri L, Sayed S, Topazian H, Welch J, Williams MJ, Duncan K. The Kenya cancer research and control stakeholder program: Evaluating a bilateral partnership to strengthen national cancer efforts. J Cancer Policy 2018; 17:38-44. [PMID: 37020928 PMCID: PMC10072854 DOI: 10.1016/j.jcpo.2017.03.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Background In response to a growing cancer burden and need for improved coordination among stakeholders in Kenya, the US National Cancer Institute and the Kenya Ministry of Health collaboratively hosted a stakeholder meeting in 2014 which identified four priority areas of need (research capacity building, pathology and cancer registries, cancer awareness and education, and health system strengthening) and developed corresponding action plans. Methods Surveys were conducted with participants to collect input on the progress and impact of the 2014 stakeholder meeting. Findings Of 69 eligible participants, 45 responded from academia, healthcare institutions, civil society, government, and international agencies. Of the four technical focus areas, three have continued to conduct working group meetings and two have conducted in-person meetings to review and update their respective action plans. Accomplishments linked to or enhanced by t meeting include: Kenyan and international support for expansion of population-based cancer registries, increased availability of prioritized diagnostic tests in selected regional referral hospitals, a greater focus on development of a national cancer research agenda, strategic planning for a community education strategy for cancer awareness, and improved coordination of partners through in-country technical assistance. Interpretation The Stakeholder Program has successfully united individuals and organizations to improve cancer control planning in Kenya, and has enhanced existing efforts and programs across the country. This model of partners working in parallel on prioritized track activities has supported development of long term coordination of cancer research and control activities sustainable by the Kenyan government and Kenyan institutions.
Collapse
Affiliation(s)
- C Morgan
- U.S. National Cancer Institute, Center for Global Health, United States
| | - M Cira
- Leidos Biomedical Research, Inc. Consultant, supporting the Center for Global Health at the U.S. National Cancer Institute, United States
- Kenya Network of Cancer Organizations, Kenya
| | - A Karagu
- National Cancer Institute of Kenya, Kenya
- Division of Non-Communicable Diseases, Ministry of Health, Kenya
| | - FC Asirwa
- Indiana University, Indianapolis, United States
- Moi University/Moi Teaching and Referral Hospital’s Academic Model of Providing Access to HealthCare (AMPATH), Kenya
| | - NR Brand
- Leidos Biomedical Research, Inc. Consultant, supporting the Center for Global Health at the U.S. National Cancer Institute, United States
- Columbia University College of Physicians and Surgeons, School of Medicine, New York, New York, United States
| | - N Buchanan Lunsford
- Centers for Disease Control and Prevention, Division of Cancer Prevention and Control, Epidemiology and Applied Research Branch, Atlanta, Georgia, United States
| | - SM Dawsey
- U.S. National Cancer Institute, Division of Cancer Epidemiology and Genetics, United States
| | - A Galassi
- U.S. National Cancer Institute, Center for Global Health, United States
| | - A Korir
- Kenya National Cancer Registry, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya
| | - L Kupfer
- U.S. National Institutes of Health, Fogarty International Center, Center for Global Health Studies
| | - PJ Loehrer
- Indiana University Melvin and Bren Simon Cancer Center, United States
| | - D Makumi
- Kenya Network of Cancer Organizations, Kenya
- The Aga Khan University Hospital, Nairobi, Kenya
| | - L Muchiri
- School of Medicine, University of Nairobi, Kenya
| | - S Sayed
- The Aga Khan University Hospital, Nairobi, Kenya
| | - H Topazian
- Harvard T.H. Chan School of Public Health, United States
| | - J Welch
- U.S. National Cancer Institute, Center for Global Health, United States
| | - MJ Williams
- U.S. National Cancer Institute, Center for Global Health, United States
| | - K Duncan
- U.S. National Cancer Institute, Center for Global Health, United States
- Corresponding Author: Center for Global Health, National Cancer Institute, National Institutes of Health, 9609 Medical, Center Drive, Rockville, MD 20850, USA,
| |
Collapse
|
11
|
Müller D, Seifried M, Knoll C, Welch J, Weinberger P. Unsaturated Aryl and Heteroaryl N1-Tetrazoles from 1-Allyl-1H-tetrazole. SYNTHESIS-STUTTGART 2018. [DOI: 10.1055/s-0036-1591879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Unsaturated aryl- and heteroaryl N1-substituted tetrazoles have been exceedingly difficult to access but are nonetheless highly attractive for the preparation of novel multifunctional spin crossover materials. The development of a Heck cross-coupling protocol, featuring good substrate tolerance for aromatic and heteroaromatic substrates overcoming this synthetic challenge is presented. The combination of aqueous THF, triethylamine, and PdCl2/P(o-tolyl)3 gave fast reaction rates and good yields. Competition experiments with styrene evidenced a slight preference for reaction with 1-allyl-1H-tetrazole.
Collapse
Affiliation(s)
- Danny Müller
- Institute of Applied Synthetic Chemistry, TU Wien
| | | | | | | | | |
Collapse
|
12
|
Abstract
Aims and methodWe explored the views of foundation doctors on psychiatry placements to inform further post development. Following criticism of some South Thames Foundation School (STFS) psychiatry placements, STFS staff reviewed existing information on post quality and 21 foundation doctors in psychiatry posts took part in three focus groups.ResultsTrainees are concerned about the general quality of posts (including supervision and induction); isolation of mental health trusts from ‘acute’ trusts; the professional position of junior psychiatrists; and responsibilities related to the Mental Health Act and risk assessment. Requirements for posts to address these issues have been developed and are now being implemented locally.Clinical implicationsThe conclusions are relevant to the quality management of foundation posts in mental health trusts, responses to the Collins Report (2010) and future recruitment into psychiatry.
Collapse
|
13
|
Affiliation(s)
- Martin Wiese
- University Hospital Lewisham, Lewisham High Street, London SE13 6LH.
| | | | | | | |
Collapse
|
14
|
Jones M, Welch J, Turvey J, Cannon J, Clark P, Szram J, Cullinan P. Prevalence of sensitization to 'improver' enzymes in UK supermarket bakers. Allergy 2016; 71:997-1000. [PMID: 26836630 DOI: 10.1111/all.12854] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/27/2016] [Indexed: 11/29/2022]
Abstract
BACKGROUND Supermarket bakers are exposed not only to flour and alpha-amylase but also to other 'improver' enzymes, the nature of which is usually shrouded by commercial sensitivity. We aimed to determine the prevalence of sensitization to 'improver' enzymes in UK supermarket bakers. METHODS We examined the prevalence of sensitization to enzymes in 300 bakers, employed by one of two large supermarket bakeries, who had declared work-related respiratory symptoms during routine health surveillance. Sensitization was determined using radioallergosorbent assay to eight individual enzymes contained in the specific 'improver' mix used by each supermarket. RESULTS The prevalence of sensitization to 'improver' enzymes ranged from 5% to 15%. Sensitization was far more likely if the baker was sensitized also to either flour or alpha-amylase. The prevalence of sensitization to an 'improver' enzyme did not appear to be related to the concentration of that enzyme in the mix. CONCLUSIONS We report substantial rates of sensitization to enzymes other than alpha-amylase in UK supermarket bakers; in only a small proportion of bakers was there evidence of sensitization to 'improver mix' enzymes without sensitization to either alpha-amylase or flour. The clinical significance of these findings needs further investigation, but our findings indicate that specific sensitization in symptomatic bakers may not be identified without consideration of a wide range of workplace antigens.
Collapse
Affiliation(s)
- M. Jones
- Department of Occupational and Environmental Medicine; Imperial College and Royal Brompton; London UK
| | - J. Welch
- Department of Occupational and Environmental Medicine; Imperial College and Royal Brompton; London UK
| | - J Turvey
- Department of Occupational and Environmental Medicine; Imperial College and Royal Brompton; London UK
| | - J. Cannon
- Department of Occupational and Environmental Medicine; Harefield NHS Trust; London UK
| | - P. Clark
- Department of Occupational and Environmental Medicine; Imperial College and Royal Brompton; London UK
| | - J. Szram
- Department of Occupational and Environmental Medicine; Imperial College and Royal Brompton; London UK
| | - P. Cullinan
- Department of Occupational and Environmental Medicine; Imperial College and Royal Brompton; London UK
| |
Collapse
|
15
|
Obeyesekera S, Jones K, Forster GE, Welch J, Brook MG, Daniels D. Management of rape/sexual assault cases within genitourinary medicine clinics: results from a study in North Thames. Int J STD AIDS 2016; 18:61-2. [PMID: 17326866 DOI: 10.1258/095646207779949952] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
A regional audit was undertaken to evaluate current practice in the management of survivors of sexual assault (SA) seen in genitourinary (GU) medicine clinics in the North Thames. The majority of the survivors were women. Most were fast-tracked, or seen in dedicated SA clinics. Over 60% of staff had specific training in management of SA. Core services provided included screening and treatment for sexually transmitted infections, emotional support, emergency contraception and hepatitis B vaccination. The sexual health needs of these survivors of SA are being met by most clinics. The development and use of a standardized care proforma across the region may be a means to further improve the care provided.
Collapse
Affiliation(s)
- S Obeyesekera
- Ambrose King Centre, Royal London Hospital, Whitechapel Road, London E1 1BB, UK.
| | | | | | | | | | | |
Collapse
|
16
|
Affiliation(s)
- Jan Welch
- The Haven, Department of Sexual Health, King's College Hospital, Denmark Hill, London SE5 9RS, UK.
| | | |
Collapse
|
17
|
Canizales J, Welch J, Fitzgerald B, Lightfoot Z, Banya W, Feary J, Cullinan P, Jones M. P53 Determination of specific IgE antibodies to mouse proteins in laboratory animal workers: Abstract P53 Table 1. Thorax 2015. [DOI: 10.1136/thoraxjnl-2015-207770.190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
18
|
Stephens T, Beane A, De Silva AP, Welch J, Sigera C, De Alwis S, Athapattu P, Peiris L, Siriwardana S, Jayasinghe KSA, Dondorp A, Haniffa R. Capacity building for critical care skills training provision in resource limited settings: the nursing intensive care skills training (nicst) project. Intensive Care Med Exp 2015. [PMCID: PMC4797402 DOI: 10.1186/2197-425x-3-s1-a444] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
19
|
|
20
|
Abstract
BACKGROUND Clinical leadership is considered essential for maintaining and improving patient care and safety in the UK, and is incorporated in the curriculum for all trainee doctors. CONTEXT Despite the growing focus on the importance of leadership, and the introduction of the Medical Leadership Competency Framework (MLCF) in the UK, leadership education for doctors in training is still in its infancy. Assessment is focused on clinical skills, and trainee doctors receive very little formal feedback on their leadership competencies. INNOVATION In this article we describe the approach taken by Health Education Kent, Sussex and Surrey (HEKSS) to raise the profile of leadership amongst doctors in training in the South Thames Foundation School (STFS). An annual structured formative assessment in leadership for each trainee has been introduced, supported by leadership education for both trainees and their supervisors in HEKSS trusts. We analysed over 500 of these assessments from the academic year 2012/13 for foundation doctors in HEKSS trusts, in order to assess the quality of the feedback. From the analysis, potential indicators of more effective formative assessments were identified. These may be helpful in improving the leadership education programme for future years. IMPLICATIONS There is a wealth of evidence to highlight the importance and value of formative assessments; however, particularly for foundation doctors, these have typically been focused on assessing clinical capabilities. This HEKSS initiative encourages doctors to recognise leadership opportunities at the beginning of their careers, seeks to help them understand the importance of acquiring leadership skills and provides structured feedback to help them improve. Leadership education for doctors in training is still in its infancy.
Collapse
Affiliation(s)
- Lindsay Hadley
- Postgraduate Medical Education, School of Clinical Leadership, Health Education Kent, Surrey and Sussex, London, UK
| | - David Black
- Postgraduate Medical Education, School of Clinical Leadership, Health Education Kent, Surrey and Sussex, London, UK
| | - Jan Welch
- South Thames Foundation School, Health Education Kent, Surrey and Sussex, London, UK
| | - Peter Reynolds
- Neonatology Department, Ashford and St Peter's Hospitals Trust, Chertsey, Surrey, UK
| | - Clare Penlington
- Postgraduate Medical Education, Queen Mary, University of London, UK
| |
Collapse
|
21
|
Braidy N, Zarka M, Welch J, Bridge W. Therapeutic Approaches to ModulatingGlutathione Levels as a Pharmacological strategy in Alzheimer's Disease. Curr Alzheimer Res 2015:CAR-EPUB-66149. [PMID: 25817250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2014] [Accepted: 03/12/2015] [Indexed: 06/04/2023]
Abstract
Accumulating evidence has suggested the involvement of oxidative stress in the pathogenesis of Alzheimer's disease (AD).The main endogenousantioxidant,glutathione (GSH),has been shown to decline with ageing and in several age-related degenerative diseases, including AD. Potential options for replenishing GSH levels as a therapeutic target to treat these conditions include the administration of GSH itself, and low toxicity forms of the limiting amino acid for GSH synthesis; cysteineHowever, passive GSH uptake is limited due to an unfavourable concentration gradient between the plasma and cytosol. Similarly, cysteine prodrugs have demonstrated limited efficacyto elevatedepleted GSH levels in several in vivo and in vitro models of disease.It has beensuggestedthat the decline in GSH levels in AD, may be associated with down regulation ofGSH homeostasis rather than substrate limitation. Cellular GSH homeostasis is regulatedby non-allosteric feedback inhibition exerted by GSH on glutamate cysteine ligase (GCL), which is responsible for the synthesis of the GSH precursor γ-glutamylcysteine (GGC). In conditions involving down regulated GSH homeostasis, GGC serves asa crucialrate-limiting substrate for GSH synthetase, the main enzyme responsible for condensing glycine with GGC to form the final thiol tripeptide, GSH. In this review, we focus on the therapeutic potential of GGC to elevate cellular GSH levels. We also discuss the efficacy of GGC prodrugs which would be taken up and converted by the unregulated GS to GSH,andthe administration of modified GSH compounds, such as GSH esters that could potentially overcome the concentration gradient that prohibits passive GSH uptake, in AD.
Collapse
Affiliation(s)
- N Braidy
- Centre for Healthy Ageing, School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.
| | | | | | | |
Collapse
|
22
|
Marinelli A, Ratner D, Lutman AA, Turner J, Welch J, Decker FJ, Loos H, Behrens C, Gilevich S, Miahnahri AA, Vetter S, Maxwell TJ, Ding Y, Coffee R, Wakatsuki S, Huang Z. High-intensity double-pulse X-ray free-electron laser. Nat Commun 2015; 6:6369. [PMID: 25744344 PMCID: PMC4366525 DOI: 10.1038/ncomms7369] [Citation(s) in RCA: 159] [Impact Index Per Article: 17.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2014] [Accepted: 01/22/2015] [Indexed: 11/21/2022] Open
Abstract
The X-ray free-electron laser has opened a new era for photon science, improving the X-ray brightness by ten orders of magnitude over previously available sources. Similar to an optical laser, the spectral and temporal structure of the radiation pulses can be tailored to the specific needs of many experiments by accurately manipulating the lasing medium, that is, the electron beam. Here we report the generation of mJ-level two-colour hard X-ray pulses of few femtoseconds duration with an XFEL driven by twin electron bunches at the Linac Coherent Light Source. This performance represents an improvement of over an order of magnitude in peak power over state-of-the-art two-colour XFELs. The unprecedented intensity and temporal coherence of this new two-colour X-ray free-electron laser enable an entirely new set of scientific applications, ranging from X-ray pump/X-ray probe experiments to the imaging of complex biological samples with multiple wavelength anomalous dispersion. Two-colour X-ray pulses from free-electron lasers can be used to probe ultrafast dynamics, but the total power is a fraction of the saturation power. Here, Marinelli et al. use twin electron bunches to reach full saturation power and increase the two-colour intensity by an order of magnitude at hard-X-ray energies.
Collapse
Affiliation(s)
- A Marinelli
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - D Ratner
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - A A Lutman
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - J Turner
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - J Welch
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - F-J Decker
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - H Loos
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - C Behrens
- 1] SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA [2] Deutsches Elektronen-Synchrotron DESY, Notkestrasse 85, Hamburg 22607, Germany
| | - S Gilevich
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - A A Miahnahri
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - S Vetter
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - T J Maxwell
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - Y Ding
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - R Coffee
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - S Wakatsuki
- 1] SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA [2] Department of Structural Biology, School of Medicine, Stanford University, Stanford, California 94305, USA
| | - Z Huang
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| |
Collapse
|
23
|
Ratner D, Abela R, Amann J, Behrens C, Bohler D, Bouchard G, Bostedt C, Boyes M, Chow K, Cocco D, Decker FJ, Ding Y, Eckman C, Emma P, Fairley D, Feng Y, Field C, Flechsig U, Gassner G, Hastings J, Heimann P, Huang Z, Kelez N, Krzywinski J, Loos H, Lutman A, Marinelli A, Marcus G, Maxwell T, Montanez P, Moeller S, Morton D, Nuhn HD, Rodes N, Schlotter W, Serkez S, Stevens T, Turner J, Walz D, Welch J, Wu J. Experimental demonstration of a soft x-ray self-seeded free-electron laser. Phys Rev Lett 2015; 114:054801. [PMID: 25699448 DOI: 10.1103/physrevlett.114.054801] [Citation(s) in RCA: 54] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/03/2014] [Indexed: 05/19/2023]
Abstract
The Linac Coherent Light Source has added a self-seeding capability to the soft x-ray range using a grating monochromator system. We report the demonstration of soft x-ray self-seeding with a measured resolving power of 2000-5000, wavelength stability of 10(-4), and an increase in peak brightness by a factor of 2-5 across the photon energy range of 500-1000 eV. By avoiding the need for a monochromator at the experimental station, the self-seeded beam can deliver as much as 50-fold higher brightness to users.
Collapse
Affiliation(s)
- D Ratner
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - R Abela
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
| | - J Amann
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - C Behrens
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - D Bohler
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - G Bouchard
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - C Bostedt
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - M Boyes
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - K Chow
- Lawrence Berkeley National Laboratory (LBNL), 1 Cyclotron Road, Berkeley, California 94720, USA
| | - D Cocco
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - F J Decker
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - Y Ding
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - C Eckman
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - P Emma
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - D Fairley
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - Y Feng
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - C Field
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - U Flechsig
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland
| | - G Gassner
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - J Hastings
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - P Heimann
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - Z Huang
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - N Kelez
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - J Krzywinski
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - H Loos
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - A Lutman
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - A Marinelli
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - G Marcus
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - T Maxwell
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - P Montanez
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - S Moeller
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - D Morton
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - H D Nuhn
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - N Rodes
- Lawrence Berkeley National Laboratory (LBNL), 1 Cyclotron Road, Berkeley, California 94720, USA
| | - W Schlotter
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - S Serkez
- Deutsches Elektronen-Synchrotron (DESY), Notkestrasse 85, D-22607 Hamburg, Germany
| | - T Stevens
- Lawrence Berkeley National Laboratory (LBNL), 1 Cyclotron Road, Berkeley, California 94720, USA
| | - J Turner
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - D Walz
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - J Welch
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| | - J Wu
- SLAC National Accelerator Laboratory, Menlo Park, California 94720, USA
| |
Collapse
|
24
|
Lutman AA, Decker FJ, Arthur J, Chollet M, Feng Y, Hastings J, Huang Z, Lemke H, Nuhn HD, Marinelli A, Turner JL, Wakatsuki S, Welch J, Zhu D. Demonstration of single-crystal self-seeded two-color x-ray free-electron lasers. Phys Rev Lett 2014; 113:254801. [PMID: 25554887 DOI: 10.1103/physrevlett.113.254801] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/12/2014] [Indexed: 05/24/2023]
Abstract
A scheme for generating two simultaneous hard-x-ray free-electron laser pulses with a controllable difference in photon energy is described and then demonstrated using the self-seeding setup at the Linac Coherent Light Source (LCLS). The scheme takes advantage of the existing LCLS equipment, which allows two independent rotations of the self-seeding diamond crystal. The two degrees of freedom are used to select two nearby crystal reflections, causing two wavelengths to be present in the forward transmitted seeding x-ray pulse. The free-electron laser system must support amplification at both desired wavelengths.
Collapse
Affiliation(s)
- A A Lutman
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - F-J Decker
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J Arthur
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - M Chollet
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Y Feng
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J Hastings
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - Z Huang
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - H Lemke
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - H-D Nuhn
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - A Marinelli
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J L Turner
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - S Wakatsuki
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J Welch
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - D Zhu
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| |
Collapse
|
25
|
Jones M, Welch J, Turvey J, Cannon J, Fitzgerald B, Szram J, Cullinan P. S5 Prevalence Of Ige Sensitisation To 'improver Mix' Enzymes Among Symptomatic Bakers Working In Uk Scratch Bakeries. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
26
|
Cannon J, Jones M, Welch J, Fitzgerald B, Szram J, Cullinan P. P135 Prevalence Of Sensitisation To Soya Flour In The Baking Industry Within The Uk. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.276] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
27
|
Abstract
This paper describes the healthcare needs of victims of multiple perpetrator sexual assault (MPSA) and single perpetrator sexual assault (SPSA) presenting to the Haven sexual assault referral centre in south-east London, and aims to identify any characteristics that might be related to attendance at follow-up appointments. We reviewed standardised casenotes of 136 MPSA victims and 139 SPSA victims attending for forensic medical examination (FME) between 1 July 2005 and 31 July 2009. MPSA victims reported a higher rate of stranger assaults, higher rates of vaginal, anal and oral rapes, more rapes at multiple anatomical sites or multiple rapes and were more likely to sustain injuries, all of which put MPSA victims at higher risk of subsequent health problems. Rates of attendance at follow-up appointments were low for all (53.5%) as were rates of completion of post-exposure prophylaxis (PEP) for HIV (33.3%). Attendance at follow-up was associated with presence of anogenital injury at the time of FME. Those over the age of 30 years were less likely to attend.
Collapse
Affiliation(s)
- Louise Morgan
- Haven Camberwell, King's College Hospital NHS Foundation Trust, London, UK
| | | | - Jan Welch
- Haven Camberwell, King's College Hospital NHS Foundation Trust, London, UK
| |
Collapse
|
28
|
Abstract
A sample of 123 HIV-positive women aged 50 years and over showed high rates of late diagnosis with CD4 count <350 (71%), significant co-morbidities (90%), high rates of premature menopause (6.8%) and early menopause (6.8%) and cervical cytological abnormalities (47%). Specific interventions to improve care in this group should include yearly cervical cytology, early counselling with regard to reproductive options, menopause management and screening for sexually transmitted infections (STIs).
Collapse
Affiliation(s)
- M I Samuel
- King's College (NHS) Trust Foundation Hospital, London, UK
| | | | | | | | | | | |
Collapse
|
29
|
Jones M, Skidmore A, Glozier N, Welch J, Hunter AS, Cullinan P. Occupational egg allergy in an embryological research facility. Occup Med (Lond) 2013; 63:348-53. [DOI: 10.1093/occmed/kqt066] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
30
|
Ritson JE, Welch J. The management of open globe eye injuries: a discussion of the classification, diagnosis and management of open globe eye injuries. J R Nav Med Serv 2013; 99:127-130. [PMID: 24511795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Eye injuries occurred in 10% of UK military major trauma cases in Iraq and Afghanistan between 2004 and 2008, with 33% of these eye injuries open globe in nature(1). This article will consider the diagnosis, classification and management of open globe injuries in the role 1/ pre-hospital environment.
Collapse
Affiliation(s)
- J E Ritson
- Acute Care Common Stem (Emergency Medicine) Core Training Year 2, Royal Navy
| | - J Welch
- FRCOphth Consultant Ophthalmologist, Royal Navy
| |
Collapse
|
31
|
Ding Y, Decker FJ, Emma P, Feng C, Field C, Frisch J, Huang Z, Krzywinski J, Loos H, Welch J, Wu J, Zhou F. Femtosecond x-ray pulse characterization in free-electron lasers using a cross-correlation technique. Phys Rev Lett 2012; 109:254802. [PMID: 23368472 DOI: 10.1103/physrevlett.109.254802] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/28/2012] [Indexed: 05/15/2023]
Abstract
We report the first measurements of x-ray single-pulse duration and two-pulse separation at the Linac Coherent Light Source using a cross-correlation technique involving x rays and electrons. An emittance-spoiling foil is adopted as a very simple and effective method to control the output x-ray pulse. A minimum pulse duration of about 3 fs full width at half maximum has been measured together with a controllable pulse separation (delay) between two pulses. This technique provides critical temporal diagnostics for x-ray experiments such as x-ray pump-probe studies.
Collapse
Affiliation(s)
- Y Ding
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Cheedella NKS, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JA. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol 2012; 24:1262-6. [PMID: 23247658 DOI: 10.1093/annonc/mds617] [Citation(s) in RCA: 79] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND Chemoradiation followed by surgery is the preferred treatment of localized gastroesophageal cancer (GEC). Surgery causes considerable life-altering consequences and achievement of clinical complete response (clinCR; defined as postchemoradiation [but presurgery] endoscopic biopsy negative for cancer and positron emission tomographic (PET) scan showing physiologic uptake) is an enticement to avoid/delay surgery. We examined the association between clinCR and pathologic complete response (pathCR). PATIENTS AND METHODS Two hundred eighty-four patients with GEC underwent chemoradiation and esophagectomy. The chi-square test, Fisher exact test, t-test, Kaplan-Meier method, and log-rank test were used. RESULTS Of 284 patients, 218 (77%) achieved clinCR. However, only 67 (31%) of the 218 achieved pathCR. The sensitivity of clinCR for pathCR was 97.1% (67/69), but the specificity was low (29.8%; 64/215). Of the 66 patients who had less than a clinCR, only 2 (3%) had a pathCR. Thus, the rate of pathCR was significantly different in patients with clinCR than in those with less than a clinCR (P < 0.001). CONCLUSIONS clinCR is not highly associated with pathCR; the specificity of clinCR for pathCR is too low to be used for clinical decision making on delaying/avoiding surgery. Surgery-eligible GEC patients should be encouraged to undergo surgery following chemoradiation despite achieving a clinCR.
Collapse
Affiliation(s)
- N K S Cheedella
- Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Hogan AM, Anand E, Oddy MJ, Welch J, Booth H. P47 Post-Operative Oxygen Saturation, Prescribing & Administration in Patients Undergoing Elective Orthopaedic Surgery. Thorax 2012. [DOI: 10.1136/thoraxjnl-2012-202678.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
34
|
Morgan L, Brittain B, Welch J. Multiple perpetrator sexual assault: how does it differ from assault by a single perpetrator? J Interpers Violence 2012; 27:2415-2436. [PMID: 22826532 DOI: 10.1177/0886260511433514] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Research that attempts to identify characteristic features of multiple perpetrator sexual assault (MPSA) is limited. This study compared demographic and assault related characteristics of 135 cases of MPSA with 139 cases of single perpetrator sexual assault (SPSA) reported to the Haven sexual assault referral centre, Camberwell, London, over a 4-year period, and aimed to identify any unique features of MPSA victims, perpetrators and assault type. Victims of MPSA were younger, less likely to be White, more likely to report previous self-harm and more likely to sustain injuries than victims of SPSA. Multiple perpetrators were younger, less likely to be White and more likely to be strangers to the victim than single perpetrators. The nature of the assault was different in single and multiple perpetrator cases; in MPSA, there were more completed rapes and more multiple rapes, and perpetrators were more likely to meet the victim in an outside location before carrying out the assault in a place of residence that was not the victim's. These findings add to a scant but growing evidence base.
Collapse
Affiliation(s)
- Louise Morgan
- King's College Hospital NHS Foundation Trust, London, UK.
| | | | | |
Collapse
|
35
|
Samuel I, Welch J, Tenant-Flowers M, Poulton M, Taylor C. P91 Care of HIV+ women aged 50 and over: can we do better? Br J Vener Dis 2012. [DOI: 10.1136/sextrans-2012-050601c.91] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
36
|
Cannon J, Szram J, Welch J, Sharp C, Cullinan P, Jones M. S6 Supermarket bakers asthma: a report of three successive rounds of surveillance. Thorax 2011. [DOI: 10.1136/thoraxjnl-2011-201054b.6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
37
|
Caswell RJ, Phillips D, Chaponda M, Khoo SH, Taylor GP, Ghanem M, Poulton M, Welch J, Gibbons S, Jackson V, Lambert JS. Utility of therapeutic drug monitoring in the management of HIV-infected pregnant women in receipt of lopinavir. Int J STD AIDS 2011; 22:11-4. [PMID: 21364060 DOI: 10.1258/ijsa.2009.009184] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The pharmacokinetics of antiretroviral drugs in pregnancy is poorly understood. We reviewed the use of therapeutic drug monitoring (TDM) in clinical settings to document plasma concentrations of lopinavir during pregnancy and investigated how clinicians acted upon TDM results. A retrospective review was carried out of all HIV-infected pregnant women taking boosted lopinavir-based highly active antiretroviral therapy (HAART) at five National Health Service (NHS) centres in the UK between May 2004 and March 2007. Seventy-three women in receipt of lopinavir were identified, of whom 89% had plasma lopinavir concentrations above the suggested minimum recommended for wild-type HIV. Initial TDM results prompted dosage change in 10% and assessment of adherence and/or pharmacist review in 11%. TDM was repeated in 29%. TDM can play an important role in the clinical management of HIV-positive pregnant women, allowing informed dose modification and an alternative measure of adherence.
Collapse
Affiliation(s)
- R J Caswell
- Department of GU Medicine and Teaching Primary Care Trust, Coventry PCT, Coventry
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
|
39
|
Welch J, Vani A, Cackett P, Vallance J, Cobb C, Devlin H, Sanders R. Glaucoma surgery: trainee outcomes and implications for future training: southeast Scotland. Eye (Lond) 2010; 24:1700-7. [DOI: 10.1038/eye.2010.135] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
40
|
Van Schil PE, Baas P, Gaafar R, Maat AP, Van de Pol M, Hasan B, Klomp HM, Abdelrahman AM, Welch J, van Meerbeeck JP. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J 2010; 36:1362-9. [PMID: 20525721 DOI: 10.1183/09031936.00039510] [Citation(s) in RCA: 163] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The European Organisation for Research and Treatment of Cancer (EORTC; protocol 08031) phase II trial investigated the feasibility of trimodality therapy consisting of induction chemotherapy followed by extrapleural pneumonectomy and post-operative radiotherapy in patients with malignant pleural mesothelioma (with a severity of cT3N1M0 or less). Induction chemotherapy consisted of three courses of cisplatin 75 mg·m⁻² and pemetrexed 500 mg·m⁻². Nonprogressing patients underwent extrapleural pneumonectomy followed by post-operative radiotherapy (54 Gy, 30 fractions). Our primary end-point was "success of treatment" and our secondary end-points were toxicity, and overall and progression-free survival. 59 patients were registered, one of whom was ineligible. Subjects' median age was 57 yrs. The subjects' TNM scores were as follows: cT1, T2 and T3, 36, 16 and six patients, respectively; cN0 and N1, 57 and one patient, respectively. 55 (93%) patients received three cycles of chemotherapy with only mild toxicity. 46 (79%) patients received surgery and 42 (74%) had extrapleural pneumonectomy with a 90-day mortality of 6.5%. Post-operative radiotherapy was completed in 37 (65%) patients. Grade 3-4 toxicity persisted after 90 days in three (5.3%) patients. Median overall survival time was 18.4 months (95% CI 15.6-32.9) and median progression-free survival was 13.9 months (95% CI 10.9-17.2). Only 24 (42%) patients met the definition of success (one-sided 90% CI 0.36-1.00). Although feasible, trimodality therapy in patients with mesothelioma was not completed within the strictly defined timelines of this protocol and adjustments are necessary.
Collapse
|
41
|
Gaafar RM, Surmont V, Scagliotti G, Van Klaveren R, Papamichael D, Welch J, Hasan B, Torri V, Van Meerbeeck JP. A double-blind, randomized, placebo-controlled phase III intergroup study of gefitinib (G) in patients (pts) with advanced NSCLC, non-progressing after first-line platinum-based chemotherapy (EORTC 08021-ILCP 01/03). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7518] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
42
|
|
43
|
Pallis AG, Gridelli C, van Meerbeeck JP, Greillier L, Wedding U, Lacombe D, Welch J, Belani CP, Aapro M. EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. Ann Oncol 2009; 21:692-706. [PMID: 19717538 DOI: 10.1093/annonc/mdp360] [Citation(s) in RCA: 118] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Non-small-cell lung cancer (NSCLC) represents a common health issue in the elderly population. Nevertheless, the paucity of large, well-conducted prospective trials makes it difficult to provide evidence-based clinical recommendations for these patients. The present paper reviews the currently available evidence regarding treatment of all stages of NSCLC in elderly patients. Surgery remains the standard for early-stage disease, though pneumonectomy is associated with higher incidence of postoperative mortality in elderly patients. Given the lack of demonstrated benefit for the use of adjuvant radiotherapy, it is also not recommended in elderly patients. Elderly patients seem to derive the same benefit from adjuvant chemotherapy as younger patients do, with no significant increase in toxicity. For locally advanced NSCLC, concurrent chemoradiotherapy may be offered to selected elderly patients as there is a higher risk for toxicity reported in the elderly population. Third-generation single-agent treatment is considered the standard of care for patients with advanced/metastatic disease. Platinum-based combination chemotherapy needs to be evaluated in prospective trials. Unfortunately, with the exception of advanced/metastatic NSCLC, prospective elderly-specific NSCLC trials are lacking and the majority of recommendations made are based on retrospective data, which might suffer from selection bias. Prospective elderly-specific trials are needed.
Collapse
Affiliation(s)
- A G Pallis
- EORTC Headquarters, EORTC-ETF, Brussels, Belgium.
| | - C Gridelli
- Division of Medical Oncology, "S.G. Moscati" Hospital, Avellino, Italy
| | - J P van Meerbeeck
- Department of Respiratory Medicine & Thoracic Oncology, Ghent University Hospital, Gent, Belgium; EORTC Lung Cancer Group, Brussels, Belgium
| | - L Greillier
- EORTC Lung Cancer Group, Brussels, Belgium; Department of Thoracic Oncology, Assistance Publique-Hôpitaux de Marseille, Faculté de Médecine, Université de la Méditerranée, Marseille, France
| | - U Wedding
- Department of Hematology, Oncology, Palliative Care, University Hospital Jena, Jena, Germany
| | - D Lacombe
- EORTC Headquarters, EORTC-ETF, Brussels, Belgium
| | - J Welch
- EORTC Headquarters, EORTC Lung Cancer Group, Brussels, Belgium
| | - C P Belani
- Department of Medicine, Penn State Cancer Hershey Institute, Hershey, USA
| | - M Aapro
- IMO Clinique de Genolier, Genolier, Switzerland
| |
Collapse
|
44
|
Ding Y, Brachmann A, Decker FJ, Dowell D, Emma P, Frisch J, Gilevich S, Hays G, Hering P, Huang Z, Iverson R, Loos H, Miahnahri A, Nuhn HD, Ratner D, Turner J, Welch J, White W, Wu J. Measurements and simulations of ultralow emittance and ultrashort electron beams in the linac coherent light source. Phys Rev Lett 2009; 102:254801. [PMID: 19659082 DOI: 10.1103/physrevlett.102.254801] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2009] [Indexed: 05/07/2023]
Abstract
The Linac Coherent Light Source (LCLS) is an x-ray free-electron laser project presently in a commissioning phase at the SLAC National Accelerator Laboratory. We report here on very low-emittance measurements made at low bunch charge, and a few femtosecond bunch length produced by the LCLS bunch compressors. Start-to-end simulations associated with these beam parameters show the possibilities of generating hundreds of GW at 1.5 A x-ray wavelength and nearly a single longitudinally coherent spike at 1.5 nm with 2-fs duration.
Collapse
Affiliation(s)
- Y Ding
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
|
46
|
Van Schil PE, Baas P, Gaafar R, Maat AP, van de Pol M, Hasan B, Klomp HM, Abdelrahman AM, Welch J, Van Meerbeeck J. Phase II feasibility trial of induction chemotherapy (ICT) followed by extrapleural pneumonectomy (EPP) and postoperative radiotherapy (PORT) for cT3N1M0 or less malignant pleural mesothelioma (MPM) (EORTC 08031). J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.7509] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7509 Background: MPM is a highly lethal disease and the role of EPP in the treatment of early stage, potentially resectable MPM remains controversial. EORTC 08031 phase II trial investigated the feasibility of trimodality therapy (TMT) consisting of ICT followed by EPP and PORT. Methods: Eligibility criteria were cT3N1M0 or less, proven MPM, < 70 years, PS 0–1, fit for TMT. ICT consisted of 3 courses of cisplatin 75mg/m2 and pemetrexed 500mg/m2 q3weeks. Non-progressing patients (pts) underwent EPP followed by PORT (54Gy, 30 fractions). Primary endpoint was “success of treatment” defined as a patient receiving the full protocol treatment, still alive 90 days after end of treatment without progression and without grade (G) 3–4 toxicity. Using a one step Fleming design 52 patients and 26 successes were required. Secondary endpoints were toxicity of TMT, overall and progression-free survival. Results: 59 pts were registered between 07/26/05 and 08/24/07, 1 was ineligible. Median age was 57 years (range 26–67), M/F 46/12, all proven MPM (31 epithelial, 18 mixed, 9 other). All pts underwent mediastinoscopy, cT1/T2/T3: 36/16/6, cN0/N1: 57/1. 55 pts received 3 cycles of ICT. G3–4 toxicity related to ICT was rare. 46 pts (79%) were operated, 42 (74%) had EPP. R0/1/2: 30/10/3, 6 were re-operated, pT0/1/2/3/4: 2/5/19/15/4, pN0/1/2/3: 34/2/6/2, 90-day mortality: 3 pts (6.5%); in 38 pts (83%) postoperative complications occurred. PORT was initiated in 38 pts and completed in 37 (65%). After PORT 2 pts (3.5%) died due to infection. Persisting G3/4 toxicity after 90 days: 3 pts (5.3%) due to radiation pneumonitis and bronchopleural fistula. After median follow- up of 19.3 months (mos) median overall survival time was 18.4 mos (95% CI 14.8-NR) and median progression-free survival was 13.9 mos (95% CI 10.9–17.1). Only 24 pts (42%) met the definition of success (one-sided 90% CI 0.36–1.00). Conclusions: EORTC 08031 investigated the feasibility of TMT in pts with proven MPM. Due to the low proportion of “successes” this TMT is not considered to be feasible. Although overall results were similar to other series, adjustments to this TMT are necessary. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- P. E. Van Schil
- Antwerp University Hospital, Edegem, Belgium; Netherlands Cancer Institute, Amsterdam, Netherlands; National Cancer Institute, Cairo, Egypt; Erasmus University, Rotterdam, Netherlands; Dr. Bernard Verbeeten Institution, Tilburg, Netherlands; EORTC, Brussels, Belgium; University of Ghent, Ghent, Belgium
| | - P. Baas
- Antwerp University Hospital, Edegem, Belgium; Netherlands Cancer Institute, Amsterdam, Netherlands; National Cancer Institute, Cairo, Egypt; Erasmus University, Rotterdam, Netherlands; Dr. Bernard Verbeeten Institution, Tilburg, Netherlands; EORTC, Brussels, Belgium; University of Ghent, Ghent, Belgium
| | - R. Gaafar
- Antwerp University Hospital, Edegem, Belgium; Netherlands Cancer Institute, Amsterdam, Netherlands; National Cancer Institute, Cairo, Egypt; Erasmus University, Rotterdam, Netherlands; Dr. Bernard Verbeeten Institution, Tilburg, Netherlands; EORTC, Brussels, Belgium; University of Ghent, Ghent, Belgium
| | - A. P. Maat
- Antwerp University Hospital, Edegem, Belgium; Netherlands Cancer Institute, Amsterdam, Netherlands; National Cancer Institute, Cairo, Egypt; Erasmus University, Rotterdam, Netherlands; Dr. Bernard Verbeeten Institution, Tilburg, Netherlands; EORTC, Brussels, Belgium; University of Ghent, Ghent, Belgium
| | - M. van de Pol
- Antwerp University Hospital, Edegem, Belgium; Netherlands Cancer Institute, Amsterdam, Netherlands; National Cancer Institute, Cairo, Egypt; Erasmus University, Rotterdam, Netherlands; Dr. Bernard Verbeeten Institution, Tilburg, Netherlands; EORTC, Brussels, Belgium; University of Ghent, Ghent, Belgium
| | - B. Hasan
- Antwerp University Hospital, Edegem, Belgium; Netherlands Cancer Institute, Amsterdam, Netherlands; National Cancer Institute, Cairo, Egypt; Erasmus University, Rotterdam, Netherlands; Dr. Bernard Verbeeten Institution, Tilburg, Netherlands; EORTC, Brussels, Belgium; University of Ghent, Ghent, Belgium
| | - H. M. Klomp
- Antwerp University Hospital, Edegem, Belgium; Netherlands Cancer Institute, Amsterdam, Netherlands; National Cancer Institute, Cairo, Egypt; Erasmus University, Rotterdam, Netherlands; Dr. Bernard Verbeeten Institution, Tilburg, Netherlands; EORTC, Brussels, Belgium; University of Ghent, Ghent, Belgium
| | - A. M. Abdelrahman
- Antwerp University Hospital, Edegem, Belgium; Netherlands Cancer Institute, Amsterdam, Netherlands; National Cancer Institute, Cairo, Egypt; Erasmus University, Rotterdam, Netherlands; Dr. Bernard Verbeeten Institution, Tilburg, Netherlands; EORTC, Brussels, Belgium; University of Ghent, Ghent, Belgium
| | - J. Welch
- Antwerp University Hospital, Edegem, Belgium; Netherlands Cancer Institute, Amsterdam, Netherlands; National Cancer Institute, Cairo, Egypt; Erasmus University, Rotterdam, Netherlands; Dr. Bernard Verbeeten Institution, Tilburg, Netherlands; EORTC, Brussels, Belgium; University of Ghent, Ghent, Belgium
| | - J. Van Meerbeeck
- Antwerp University Hospital, Edegem, Belgium; Netherlands Cancer Institute, Amsterdam, Netherlands; National Cancer Institute, Cairo, Egypt; Erasmus University, Rotterdam, Netherlands; Dr. Bernard Verbeeten Institution, Tilburg, Netherlands; EORTC, Brussels, Belgium; University of Ghent, Ghent, Belgium
| |
Collapse
|
47
|
Affiliation(s)
- Bernadette Butler
- The Haven Camberwell, King's College Hospital, NHS Foundation Trust, Denmark Hill, London, UK
| | | |
Collapse
|
48
|
Ellis JR, Nathan PJ, Villemagne VL, Mulligan RS, Saunder T, Young K, Smith CL, Welch J, Woodward M, Wesnes KA, Savage G, Rowe CC. Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET. Psychopharmacology (Berl) 2009; 202:79-91. [PMID: 18949462 DOI: 10.1007/s00213-008-1347-9] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2008] [Accepted: 09/19/2008] [Indexed: 01/25/2023]
Abstract
INTRODUCTION The nicotinic acetylcholine receptor (nAChR) system plays a regulatory role in a number of cognitive processes. Cholinesterase inhibitors (i.e., galantamine) that potentiate cholinergic neurotransmission improve cognitive function in Alzheimer's disease (AD); however, the relationship between these effects and associated changes in nAChRs are yet to be established in vivo. MATERIALS AND METHODS 2-[18F]Fluoro-A-85380 (2-FA) binds to nAChRs and with positron emission tomography (PET) imaging provides a composite measure of receptor density and ligand affinity. This study aimed to: (1) quantify nAChRs in vivo in 15 drug-naïve patients with mild AD before and after chronic treatment with galantamine, using 2-FA and PET, and (2) examine the relationship between treatment-induced changes in nAChRs and improvements in cognitive function. Participants were nonsmokers and underwent extensive cognitive testing and a PET scan after injection of approximately 200 MBq of 2-FA on two occasions (before and after 12 weeks, galantamine treatment). A 3-day washout period preceded the second scan. Brain regional 2-FA binding was assessed through a simplified estimation of distribution volume (DV(S)). RESULTS Performance on global measures of cognition significantly improved following galantamine treatment (p < 0.05). This improvement extended to specific cognitive measures of language and verbal learning. No significant differences in nAChR DV(S) before and after galantamine treatment were found. The treatment-induced improvement in cognition was not correlated with regional or global nAChR DV(S), suggesting that changes in nAChRs may not be responsible for the improvements in cognition following galantamine in patients with mild AD.
Collapse
Affiliation(s)
- J R Ellis
- School of Psychology, Psychiatry, and Psychological Medicine, Monash University, Melbourne, Victoria, Australia.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Read P, Costelloe S, Mullen J, O'Shea S, Lyons F, Hay P, Welch J, Larbalestier N, Taylor GP, de Ruiter A. New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines*. HIV Med 2008; 9:448-51. [DOI: 10.1111/j.1468-1293.2008.00594.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Samuel MI, Welch J, Tenant-Flowers M, Brady M, Poulton M, Savvas M, Kumar U, Taylor C. Contraception and medical gynaecology for HIV-positive women in a one-stop clinic. Int J STD AIDS 2008; 19:559-60. [DOI: 10.1258/ijsa.2008.008009] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
HIV-positive women may be reluctant to attend gynaecology or family planning clinics for fear of divulging their condition. Therefore, a referral clinic was opened within the HIV clinic. Retrospective case-note reviews of 197 new patients revealed 109 with a variety of medical gynaecology conditions (menorrhagia being the commonest) and 88 sought contraception. The full range of contraceptives was used, including Mirena for the treatment of menorrhagia as well as contraception and the combined pill adjusted for interaction with liver enzyme-inducing antiretroviral drugs. The acceptance of contraceptive advice and gynaecological evaluation by the patients has resulted in improved reproductive health services for these HIV-positive women. In centres with large cohorts of HIV-positive women, this type of one-stop specialist clinic will be very effective in providing high-quality reproductive health care and hence, this type of clinic is recommended for such centres.
Collapse
Affiliation(s)
- M I Samuel
- Department of Sexual Health, The Caldecot Centre, King's College Hospital NHS Foundation Trust, Denmark Hill, Londo SE5 9RS
| | - J Welch
- Department of Sexual Health, The Caldecot Centre, King's College Hospital NHS Foundation Trust, Denmark Hill, Londo SE5 9RS
| | - M Tenant-Flowers
- Department of Sexual Health, The Caldecot Centre, King's College Hospital NHS Foundation Trust, Denmark Hill, Londo SE5 9RS
| | - M Brady
- Department of Sexual Health, The Caldecot Centre, King's College Hospital NHS Foundation Trust, Denmark Hill, Londo SE5 9RS
| | - M Poulton
- Department of Sexual Health, The Caldecot Centre, King's College Hospital NHS Foundation Trust, Denmark Hill, Londo SE5 9RS
| | - M Savvas
- Department of Gynaecology, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK
| | - U Kumar
- Department of Sexual Health, The Caldecot Centre, King's College Hospital NHS Foundation Trust, Denmark Hill, Londo SE5 9RS
| | - C Taylor
- Department of Sexual Health, The Caldecot Centre, King's College Hospital NHS Foundation Trust, Denmark Hill, Londo SE5 9RS
| |
Collapse
|